Details for New Drug Application (NDA): 017087
✉ Email this page to a colleague
The generic ingredient in ETHRANE is enflurane. There are three drug master file entries for this compound. Additional details are available on the enflurane profile page.
Summary for 017087
Tradename: | ETHRANE |
Applicant: | Baxter Hlthcare |
Ingredient: | enflurane |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 017087
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | LIQUID;INHALATION | Strength | 99.9% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017087
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | ETHRANE | enflurane | LIQUID;INHALATION | 017087-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | ETHRANE | enflurane | LIQUID;INHALATION | 017087-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription